Impact of Ibis on Patients With Advanced COPD

Senscio Systems

Status: Unknown

Conditions: COPD

Treatments: Behavioral: Digital Therapeutics

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT03131622

Senscio-001

Details and patient eligibility

About

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients with COPD.

Enrollment: 240 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Gold Stage II with a CAT Score above 19
• Gold Stage III/IV with a CAT Score above 14

Exclusion criteria

• Cognitive or physical impediments that inhibits patients from interacting with our digital therapeutics platform.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

240 participants in 2 patient groups

Digital Therapeutics

Experimental group

Description:

Patients assigned to the digital therapeutics arm will receive Ibis and all the associate services.

Treatment:

Behavioral: Digital Therapeutics

Control

No Intervention group